Hosoglu, S. (2018) “Use of carbapenems and glycopepdides is significant risk for multidrug resistant Acinetobacter baumannii infections”, The Journal of Infection in Developing Countries, 12(02), pp. 67–72. doi: 10.3855/jidc.8081.